- Trials with a EudraCT protocol (109)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
109 result(s) found for: Schizophrenia OR PTSD.
Displaying page 1 of 6.
EudraCT Number: 2005-000223-42 | Sponsor Protocol Number: ZiSe | Start Date*: 2005-10-31 |
Sponsor Name:University Hospital Hamburg-Eppendorf, Psychiatry | ||
Full Title: Effects of ziprasidone vs. placebo during the first four weeks of eight weeks sertraline treatment in patients with posttraumatic stress disorder (PTSD) | ||
Medical condition: Post-traumatic Stress Disorder (PTSD) according to DSM-IV criteria | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-004286-18 | Sponsor Protocol Number: HPA-PTSD-1 | Start Date*: 2008-08-05 |
Sponsor Name:Central Institute of Mental Health | ||
Full Title: Monocentric, Double-blind Placebo-Controlled, Randomized Cross-Sectional Clinical Trial of Hydrocortisone (10 and 30mg/d) in Outpatients with Posttraumatic-Stress- Disorder (PTSD) ... | ||
Medical condition: Intrusions in patients with posttraumatic stress disorder | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000319-21 | Sponsor Protocol Number: ClonDO | Start Date*: 2021-12-20 |
Sponsor Name:Charité – Universitätsmedizin Berlin | ||
Full Title: Treating Nightmares in Posttraumatic Stress Disorder with the α-adrenergic Agents Clonidine and Doxazosin: A Randomized-Controlled Feasibility Study (ClonDoTrial) | ||
Medical condition: Posttraumatic Stress Disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-010966-47 | Sponsor Protocol Number: NeSSy_200901 | Start Date*: 2010-01-13 | |||||||||||
Sponsor Name:Universität Bremen | |||||||||||||
Full Title: Clinical Effectiveness Of The Newer Antipsychotic Compounds Olanzapine, Quetiapine And Aripiprazole In Comparison With Low Dose Conventional Antipsychotics (Haloperidol And Flupentixol) In Patients... | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011594-33 | Sponsor Protocol Number: SMRI-07TGF-1152 | Start Date*: 2009-11-02 | |||||||||||
Sponsor Name:LWL University Hospital Bochum, Ruhr-University Bochum | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled study of tetrabenazine as adjunctive therapy to risperidone in first-episode schizophrenia | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001015-38 | Sponsor Protocol Number: SMRI-07TAF-1152 | Start Date*: 2008-09-19 | |||||||||||
Sponsor Name:LWL University Hospital Bochum, Ruhr-University Bochum | |||||||||||||
Full Title: A randomized, placebo-controlled study of the central cannabinoid (CB1) receptor antagonist rimonabant as adjunctive therapy to improve cognition in schizophrenia | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000054-28 | Sponsor Protocol Number: OLIGOTREAT | Start Date*: 2023-06-02 | |||||||||||
Sponsor Name:Klinikum der Universität München | |||||||||||||
Full Title: Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity (OligoTreat) | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000545-35 | Sponsor Protocol Number: D1443L00015 | Start Date*: 2007-10-31 | |||||||||||
Sponsor Name:Medical Institutions of the District Oberpfalz/Bayern (MedBO GmbH) | |||||||||||||
Full Title: Quetiapine induced neuroplasticity in schizophrenic patients: A combined TMS and VBM study | |||||||||||||
Medical condition: Neuroleptika-naive patients with a first episode of schizophrenia according to DSM-IV criteria. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017852-28 | Sponsor Protocol Number: H8Y-MC-HBBM(a) | Start Date*: 2010-05-04 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Phase 2, Multicenter, Double-Blind, Placebo-Controlled Comparator Study of 2 Doses of LY2140023 versus Placebo in Patients with DSM-IVTR Schizophrenia | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-005015-28 | Sponsor Protocol Number: 1289.6 | Start Date*: 2014-10-31 | |||||||||||
Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG | |||||||||||||
Full Title: A phase II randomised, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of four orally administrated doses of BI 409306 during a 12-week treatment perio... | |||||||||||||
Medical condition: Patients with schizophrenia on stable antispychotic treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002245-20 | Sponsor Protocol Number: EICAS | Start Date*: 2008-08-15 | |||||||||||
Sponsor Name:Zentralinstitut für Seelische Gesundheit Mannheim | |||||||||||||
Full Title: Evaluation of potential central glucoregulatory compounds to treat/ameliorate the symptoms of schizophrenia: a proof-of-concept study in healthy volunteers | |||||||||||||
Medical condition: Basic ressearch on schizophrenia. This is a proof-of-concept trial. The hypothesis is that substances that regulate the central glucose utilisation might ameliorate symptoms of schizophrenic psyc... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020764-38 | Sponsor Protocol Number: A8241012 | Start Date*: 2010-12-14 | |||||||||||
Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, NY 10017, US | |||||||||||||
Full Title: PHASE 2, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL GROUP, 4-WEEK INPATIENT STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TWO FIXED DOSES OF PF-02545920 COMPARED TO PLACEBO IN THE TREATMENT OF ... | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-003340-11 | Sponsor Protocol Number: R076477SCH4026 | Start Date*: 2008-11-03 | |||||||||||
Sponsor Name:JANSSEN-CILAG GmbH | |||||||||||||
Full Title: The “therapeutic window” of the "atypical” antipsychotic paliperidone ER - A Positron Emission Tomography study with [18F]fallypride as the radiotracer | |||||||||||||
Medical condition: subchronic schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004891-10 | Sponsor Protocol Number: Vocational Rehabilitation | Start Date*: 2007-04-17 | |||||||||||
Sponsor Name:Charité - Universitätsmedizin Berlin | |||||||||||||
Full Title: Future strategies for vocational rehabilitation schizophrenia | |||||||||||||
Medical condition: The social implications and long-term consequences of mental disorders regarding sick days at work, unemployment rates and early retirement are considerable. This trial is being conducted to unders... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003437-18 | Sponsor Protocol Number: ACP-103-039 | Start Date*: 2017-10-05 | |||||||||||
Sponsor Name:ACADIA Pharmaceuticals Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (Enhance-2) | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000579-40 | Sponsor Protocol Number: D1443L00002 | Start Date*: 2007-10-10 | |||||||||||
Sponsor Name:Charité Universitätsmedizin Berlin | |||||||||||||
Full Title: Effects of atypical versus typical neuroleptics on motivation, hedonia, and social cognition in patients with schizophrenia – an fMRI study | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-002572-39 | Sponsor Protocol Number: TargetFlame | Start Date*: 2022-03-30 | |||||||||||
Sponsor Name:Bezirkskliniken Schwaben | |||||||||||||
Full Title: Effects of add-on Celecoxib treatment in patients with schizophrenia spectrum disorders and inflammatory cytokine profile (TargetFlame) | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007307-91 | Sponsor Protocol Number: H8Y-MC-HBBR | Start Date*: 2009-09-10 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Long-Term, Phase 2, Multicenter, Randomized, Open-Label, Comparative Safety Study of LY2140023 Versus Atypical Antipsychotic Standard of Care in Patients with DSM-IV-TR Schizophrenia | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000338-37 | Sponsor Protocol Number: 1723/1-1 | Start Date*: 2014-11-04 | ||||||||||||||||
Sponsor Name:Technische Universität München, vertreten durch das Klinikum rechts der Isar | ||||||||||||||||||
Full Title: Evaluation of the necessity of a pharmacological treatment with antipsychotics for the prevention of relapse in long-term stabilized schizophrenic patients: a randomized, single-blind, longitudinal... | ||||||||||||||||||
Medical condition: schizophrenia or schizoaffective disorder in remission for at least 3 years under a stable antipsychotic medication. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-000750-22 | Sponsor Protocol Number: D1441C00112 | Start Date*: 2006-04-06 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A 6-week, International, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Phase IIIb Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Immediate-release T... | |||||||||||||
Medical condition: SCHIZOPHRENIA | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.